Skip to main content
. Author manuscript; available in PMC: 2022 May 14.
Published in final edited form as: Circ Res. 2021 May 13;128(10):1514–1532. doi: 10.1161/CIRCRESAHA.121.318157

Table 1. Disease Validity Classifications for DCM Genes Considered Within a Monogenic Framework.

The 51 genes curated for DCM by the ClinGen DCM Gene Curation Panel are grouped by levels of evidence supporting a Mendelian relationship with the DCM phenotype.5 Genes meeting a classification of moderate, strong, or definitive, as defined by the ClinGen framework, have high levels of evidence that can be used for molecular diagnosis of DCM in the clinical setting. Genes with limited classifications have variable degrees of evidence, some of which may emerge as high evidence genes in the future. Genes in the minimal evidence category, assigned a “disputed” or “no known disease relationship” classification, are unlikely to accumulate evidence to reach a high classification standard. However, while highly unlikely to be a monogenic cause of DCM, it is possible that genes in this category may have a modest clinical effect as a genetic modifier of disease. Abbreviations: AD, autosomal dominant; AR; autosomal recessive; DCM, dilated cardiomyopathy; MOI, mode of inheritance; SD, semi-dominant (both AD and AR mechanisms reported).

ClinGen DCM Gene-Disease Validity Classification Gene Protein MOI Function
High Evidence Genes Moderate ACTC1 Actin, alpha cardiac 1 AD Sarcomere
Moderate ACTN2 Alpha actinin 2 AD Sarcomere
Definitive BAG3 BCL2-associated anthanogene 3 AD Co-chaperone/
Heat shock protein
Definitive DES Desmin AD Cytoskeleton
Strong DSP Desmoplakin AD Desmosome
Definitive FLNC Filamin C AD Sarcomere
Moderate JPH2 Junctophilin 2 SD Junctional membrane
Definitive LMNA Lamin A/C AD Nuclear envelope
Definitive MYH7 Myosin heavy chain 7, beta AD Sarcomere
Moderate NEXN Nexilin AD Cytoskeleton
Definitive PLN Phospholamban AD Sarcoplasmic reticulum
Definitive RBM20 RNA binding motif protein 20 AD Nucleus/RNA-binding
Definitive SCN5A Sodium channel, voltage-gated type V, alpha AD Ion channel
Definitive TNNC1 Troponin C, slow AD Sarcomere
Moderate TNNI3 Troponin I AD Sarcomere
Definitive TNNT2 Troponin T AD Sarcomere
Moderate TPM1 Tropomyosin 1 AD Sarcomere
Definitive TTN Titin AD Sarcomere
Moderate VCL Metavinculin AD Cytoskeleton
Low/ Variable Evidence Genes Limited ABCC9 ATP-binding cassette, subfamily C, member 9 AD Ion channel, sarcomere
Limited ANKRD1 Ankyrin repeat domain 1 AD Sarcomere
Limited CSRP3 Cysteine-rich protein 3 AD Cytoskeleton
Limited CTF1 Cardiotrophin 1 AD Cytokine
Limited DSG2 Desmoglein 2 AD Desmosome
Limited DTNA Dystrobrevin, Alpha AD Sarcomere
Limited EYA4 Eyes absent 4 AD Nucleus
Limited GATAD1 GATA zinc finger domain-containing protein 1 AR Nucleus
Limited ILK Integrin-linked kinase AD Cytoskeleton
Limited LAMA4 Laminin, alpha 4 AD Extracellular matrix
Limited LDB3 LIM domain binding 3 AD Cytoskeleton
Limited MYBPC3 Myosin-binding protein C AD Sarcomere
Limited MYH6 Myosin heavy chain 6, alpha AD Sarcomere
Limited MYL2 Myosin light chain 2 AD Sarcomere
Limited MYPN Myopalladin AD Sarcomere
Limited NEBL Nebulette AD Sarcomere
Limited NKX2–5 NL2 homeobox 5 AD Nucleus
Limited OBSCN Obscurin AD Sarcomere
Limited PLEKHM2 Pleckstrin homology domain-containing protein, family M, member 2 AR Cytoskeleton
Limited PRDM16 PR domain-containing protein 16 AD Nucleus
Limited PSEN2 Presenilin 2 AD Plasma membrane
Limited SGCD Sarcoglycan, delta AD Cytoskeleton
Limited TBX20 T-box 20 AD Nucleus
Limited TCAP Telethonin AD Sarcomere
Limited TNNI3K TNNI3-interacting kinase AD Sarcomere
Minimal Evidence Genes No known disease relationship LRRC10 Leucine-rich repeat-containing protein 10 AR Cytoskeleton
No known disease relationship MIB1 Mindbomb E3 ubiquitin protein ligase 1 AD Cytoskeleton
Disputed MYL3 Myosin light chain 3 AD Cytoskeleton
No known disease relationship NPPA Natriuretic peptide precursor A AR Hormone
Disputed PDLIM3 PDZ and LIM domain protein 3 AD Cytoskeleton
Disputed PKP2 Plakophilin 2 AD Desmosome
Disputed PSEN1 Presenilin 1 AD Plasma membrane